Keyphrases
Phase II Study
100%
Carcinoma
100%
Paclitaxel
100%
Biliary Tree
100%
Gallbladder Cancer
33%
Metastatic Carcinoma
33%
Adverse Effects
16%
Gallbladder
16%
Neoplasms
16%
Adenocarcinoma
16%
Days of Treatment
16%
Toxic Effects
16%
Taxanes
16%
Complete Response
16%
Cimetidine
16%
Bile Duct
16%
Diphenhydramine
16%
Hematologic
16%
Partial Response
16%
Initial Dose
16%
Bile Duct Cancer
16%
Patient Cohort
16%
Premedication
16%
Treatment Cycle
16%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoma
100%
Paclitaxel
100%
Metastasis
33%
Adverse Event
16%
Neoplasm
16%
Adenocarcinoma
16%
Toxicity
16%
Cimetidine
16%
Dexamethasone
16%
Diphenhydramine
16%
Gallbladder Carcinoma
16%
Bile Duct Cancer
16%
Taxane
16%